Flagg Flanagan, Chairman and CEO
Salt Lake City, UT
DiscGenics is a privately-held, clinical-stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. As the only company in the world to develop an allogeneic cell therapy derived from intervertebral disc cells to treat diseases of the disc, DiscGenics believes it has a unique opportunity to harness the restorative potential of the human body to heal millions of patients suffering from the debilitating effects of back pain.

By using this website you agree to accept our Privacy Policy and Terms & Conditions